Med24
metabolic-therapy 19. 10. 2026 • 2 min read • Endocrine reviews (PubMed)

The Microbiome-Metabolokine-Adipokine Axis in Insulin Resistance: Adaptive and Maladaptive FGF21-GDF15 Signaling.

Insulin resistance emerges from disturbances in interorgan metabolic communication in which nutrient exposure, microbial metabolism, and host endocrine responses interact across multiple metabolic compartments. This state-of-the-art review proposes a revised Microbiome-Metabolokine-Adipokine (MMA) Axis as a focused...

Addressing Post-Intensive Care Syndrome Among Survivors of COVID (APICS-COVID)

Insulin resistance arises from disruptions in metabolic communication involving nutrient exposure, microbial metabolism, and host endocrine responses. A revised Microbiome-Metabolokine-Adipokine (MMA) Axis is proposed to link gut microbial metabolic signals with responses in the intestine, liver, and adipose tissue.

The MMA Axis

Microbiome-derived signals, such as short-chain fatty acids and tryptophan-derived metabolites, can affect intestinal signaling, incretin secretion, hepatic nutrient sensing, and adipose lipid buffering, ultimately influencing insulin sensitivity. Within this network, fibroblast growth factor 21 (FGF21) and growth differentiation factor 15 (GDF15) are considered distinct adaptive endocrine signals. FGF21 primarily responds to nutrient and metabolic stress, while GDF15 communicates broader cellular stress.

Sponsored content

Understanding Insulin Resistance

Elevated levels of either metabolokine during insulin resistance do not necessarily indicate endocrine resistance. Progression toward insulin resistance reflects a mismatch between metabolic stress and the ability of integrated endocrine responses to maintain metabolic flexibility. Current evidence supports individual signaling modules, but a direct sequence has not been established. This revised framework provides a basis for investigating how microbiome-derived signals interact with host endocrine adaptation during insulin resistance development.

Original Scientific Source
Endocrine reviews (PubMed)
View Original Source
Medical Disclaimer All calculations, recommendations, and interpretations provided by this tool are for informational and educational purposes only. They do not substitute professional medical advice, diagnosis, or treatment. Always consult your physician regarding any health concerns.

Recommended Medical News

All news →
Nanotechnology-Driven 18F-FDG Imaging to Understand the Change in Insulin Sensitivity: Current Evidence, Methodological Gaps, and Translational Challenges.
metabolic-therapy

Nanotechnology-Driven 18F-FDG Imaging to Understand the Change in Insulin Sensitivity: Current Evidence, Methodological Gaps, and Translational Challenges.

Insulin resistance is an important metabolic derangement contributing to the pathogenesis of type 2 diabetes, obesity, metabolic syndrome, and other chronic diseases, underlining the requirement for techniques that enable in vivo analysis of tissue-specific glucose metabolism. 18F-fluorodeoxyglucose positron emission...

10. 11. 2026 Read article →
Cardiometabolic Abnormalities among Normal-Weight Adults: Prevalence and Associated Sociodemographic and Lifestyle Factors in a Large Spanish Cohort.
metabolic-therapy

Cardiometabolic Abnormalities among Normal-Weight Adults: Prevalence and Associated Sociodemographic and Lifestyle Factors in a Large Spanish Cohort.

BACKGROUND: Although body mass index (BMI) is widely used to assess obesity-related health risks, it may fail to detect individuals with normal weight who present with significant cardiometabolic abnormalities. This phenotype, often overlooked in clinical practice, is associated with increased risk of cardiovascular...

30. 10. 2026 Read article →
Advertisement